| 5 | 1/1 | 返回列表 |
| 查看: 2891 | 回復(fù): 4 | ||
gaojingmei金蟲(chóng) (著名寫(xiě)手)
|
[求助]
阿奇霉素片和膠囊的原研廠家?
|
|
阿奇霉素片和膠囊的原研廠家是究竟是哪家呢?是同一廠家?還是不同廠家?Pliva和輝瑞到底哪個(gè)才是原研廠家? 在美國(guó)是輝瑞上市早,Pliva是仿制,但在其他國(guó)家和地區(qū)的批準(zhǔn)上市情況如何呢? 請(qǐng)各位大俠鼎力相助! |
鐵桿木蟲(chóng) (職業(yè)作家)
|
Select all Show Checked azithromycin Updated on 06-MAR-2012. Originator: PLIVA dd . Highest Dev Status: Launched. DR azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine Updated on 02-MAR-2012. Originator: Medicines for Malaria Venture . Highest Dev Status: Phase 3 Clinical. DR azithromycin (ophthalmic sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Launched. DR azithromycin (sustained-release, DuraSite, ocular infection), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Discovery. DR azithromycin + dexamethasone (sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Phase 3 Clinical. DR JP-02 Updated on 13-JAN-2012. Originator: Bioagency AG . Highest Dev Status: No Development Reported. DR azithromycin (dermal formulation, Lyme disease), Ixodes Updated on 08-SEP-2011. Originator: Ixodes Gmbh . Highest Dev Status: Phase 2 Clinical. DR azithromycin + dexamethasone (sustained-release, DuraSite, bacterial ear infection), InSite Updated on 25-AUG-2011. Originator: InSite Vision Inc . Highest Dev Status: Discontinued. DR azithromycin-based macrolide antibiotics (malaria), GlaxoSmithKline/Medicines for Malaria Venture Updated on 24-AUG-2011. Originator: GlaxoSmithKline plc . Highest Dev Status: No Development Reported. DR azithromycin (sustained release, microsphere formulation), Pfizer Updated on 31-MAY-2011. Originator: Pfizer Inc . Highest Dev Status: Launched. DR azithromycin (Solumer nanoparticle, bacterial infection), Solubest Updated on 02-SEP-2009. Originator: Solubest Ltd . Highest Dev Status: No Development Reported. |
木蟲(chóng) (職業(yè)作家)
鐵桿木蟲(chóng) (職業(yè)作家)
鐵桿木蟲(chóng) (正式寫(xiě)手)
| 阿奇霉素最先是由克羅地亞普利瓦公司研制合成,并率先在前南斯拉夫上市的。為了取得更大的經(jīng)濟(jì)效益,原研發(fā)公司將全球的生產(chǎn)和市場(chǎng)開(kāi)發(fā)權(quán)進(jìn)行了轉(zhuǎn)讓,由美國(guó)輝瑞公司和意大利Sigma-Tau公司授讓進(jìn)行全球開(kāi)發(fā)。輝瑞公司在取得了全球開(kāi)發(fā)權(quán)后,其獲批的阿奇霉素商品名為希舒美。08年,希舒美在阿奇霉素的市場(chǎng)占有率達(dá)到30.78%。 |
| 5 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 335求調(diào)劑 +4 | yuyu宇 2026-03-23 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 306求0703調(diào)劑一志愿華中師范 +7 | 紙魚(yú)ly 2026-03-21 | 8/400 |
|
|
[考研] 一志愿河北工業(yè)大學(xué)0817化工278分求調(diào)劑 +7 | jhybd 2026-03-23 | 11/550 |
|
|
[考研] 279分求調(diào)劑 一志愿211 +17 | chaojifeixia 2026-03-19 | 19/950 |
|
|
[考研] 材料專碩英一數(shù)二306 +8 | z1z2z3879 2026-03-18 | 8/400 |
|
|
[考研] 一志愿南航材料專317分求調(diào)劑 +3 | 炸呀炸呀炸薯?xiàng)l 2026-03-23 | 3/150 |
|
|
[考研] 考研化學(xué)308分求調(diào)劑 +7 | 你好明天你好 2026-03-23 | 8/400 |
|
|
[考研] 求調(diào)劑一志愿海大,0703化學(xué)學(xué)碩304分,有大創(chuàng)項(xiàng)目,四級(jí)已過(guò) +6 | 幸運(yùn)哩哩 2026-03-22 | 10/500 |
|
|
[考研] 305分求調(diào)劑(食品工程) +4 | Sxy112 2026-03-21 | 6/300 |
|
|
[考研] 0805 316求調(diào)劑 +3 | 大雪深藏 2026-03-18 | 3/150 |
|
|
[考研] 求助 +5 | 夢(mèng)里的無(wú)言 2026-03-21 | 6/300 |
|
|
[基金申請(qǐng)]
學(xué)校已經(jīng)提交到NSFC,還能修改嗎?
40+4
|
babangida 2026-03-19 | 9/450 |
|
|
[考研] 求調(diào)劑 +6 | Mqqqqqq 2026-03-19 | 6/300 |
|
|
[考研] 303求調(diào)劑 +5 | 睿08 2026-03-17 | 7/350 |
|
|
[考研] 一志愿 西北大學(xué) ,070300化學(xué)學(xué)碩,總分287,雙非一本,求調(diào)劑。 +3 | 晨昏線與星海 2026-03-18 | 3/150 |
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-03-18 | 6/300 |
|
|
[考研] 329求調(diào)劑 +9 | 想上學(xué)吖吖 2026-03-19 | 9/450 |
|
|
[考研] 086500 325 求調(diào)劑 +3 | 領(lǐng)帶小熊 2026-03-19 | 3/150 |
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
[考研] 085600材料與化工求調(diào)劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|